268 related articles for article (PubMed ID: 28395108)
1. B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.
de Jong D; Roemer MG; Chan JK; Goodlad J; Gratzinger D; Chadburn A; Jaffe ES; Said J; Natkunam Y
Am J Clin Pathol; 2017 Feb; 147(2):153-170. PubMed ID: 28395108
[TBL] [Abstract][Full Text] [Related]
2. T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.
Gratzinger D; de Jong D; Jaffe ES; Chadburn A; Chan JK; Goodlad JR; Said J; Natkunam Y
Am J Clin Pathol; 2017 Feb; 147(2):188-203. PubMed ID: 28395105
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.
Chen BJ; Chapuy B; Ouyang J; Sun HH; Roemer MG; Xu ML; Yu H; Fletcher CD; Freeman GJ; Shipp MA; Rodig SJ
Clin Cancer Res; 2013 Jul; 19(13):3462-73. PubMed ID: 23674495
[TBL] [Abstract][Full Text] [Related]
4. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
5. EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency.
Satou A; Nakamura S
Cancer Med; 2021 Oct; 10(19):6777-6785. PubMed ID: 34387382
[TBL] [Abstract][Full Text] [Related]
6. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
Bienemann K; Borkhardt A; Klapper W; Oschlies I
Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
[TBL] [Abstract][Full Text] [Related]
8. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
9. HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.
Chadburn A; Said J; Gratzinger D; Chan JK; de Jong D; Jaffe ES; Natkunam Y; Goodlad JR
Am J Clin Pathol; 2017 Feb; 147(2):171-187. PubMed ID: 28395104
[TBL] [Abstract][Full Text] [Related]
10. Immunodeficiency-related Hodgkin lymphoma and its mimics.
Said JW
Adv Anat Pathol; 2007 May; 14(3):189-94. PubMed ID: 17452815
[TBL] [Abstract][Full Text] [Related]
11. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
12. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.
Green MR; Rodig S; Juszczynski P; Ouyang J; Sinha P; O'Donnell E; Neuberg D; Shipp MA
Clin Cancer Res; 2012 Mar; 18(6):1611-8. PubMed ID: 22271878
[TBL] [Abstract][Full Text] [Related]
13. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.
Quintanilla-Martinez L; de Jong D; de Mascarel A; Hsi ED; Kluin P; Natkunam Y; Parrens M; Pileri S; Ott G
J Hematop; 2009 Dec; 2(4):211-36. PubMed ID: 20309430
[TBL] [Abstract][Full Text] [Related]
14. Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142.
Sakakibara A; Kohno K; Ishikawa E; Suzuki Y; Shimada S; Eladl AE; Elsayed AA; Daroontum T; Satou A; Takahara T; Ohashi A; Takahashi E; Kato S; Nakamura S; Asano N
Pathol Int; 2020 Aug; 70(8):481-492. PubMed ID: 32367595
[TBL] [Abstract][Full Text] [Related]
15. EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.
Natkunam Y; Goodlad JR; Chadburn A; de Jong D; Gratzinger D; Chan JK; Said J; Jaffe ES
Am J Clin Pathol; 2017 Feb; 147(2):129-152. PubMed ID: 28395107
[TBL] [Abstract][Full Text] [Related]
16. Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP Workshop.
Cook JR; Amador C; Czader M; Duffield A; Goodlad J; Ott G; Xiao W; Dave S; Thakkar D; Thacker E; Dogan A; Wasik M; Nejati R
Am J Clin Pathol; 2023 Apr; ():. PubMed ID: 37186259
[TBL] [Abstract][Full Text] [Related]
17. Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases.
Kojima M; Itoh H; Shimizu K; Saruki N; Murayama K; Higuchi K; Tamaki Y; Matsumoto M; Hirabayashi K; Igarishi S; Masawa N; Nakamura S
Int J Surg Pathol; 2006 Jan; 14(1):43-8. PubMed ID: 16501834
[TBL] [Abstract][Full Text] [Related]
18. Aggressive B-cell lymphomas with a primary bone marrow presentation.
Zamò A; Johnston P; Attygalle AD; Laurent C; Arber DA; Fend F
Histopathology; 2020 Sep; 77(3):369-379. PubMed ID: 32324290
[TBL] [Abstract][Full Text] [Related]
19. 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.
Shiraiwa S; Kikuti YY; Carreras J; Kondo Y; Ohmachi K; Ogawa Y; Kawada H; Sato S; Gion Y; Sato Y; Nakamura N; Ando K
Am J Surg Pathol; 2022 Aug; 46(8):1017-1024. PubMed ID: 35848760
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
